Analysis of Ghrelin and Asymmetric Dimethylarginine (ADMA) as Endothelial Dysfunction Marker Among Obese Men

Analysis of Ghrelin and Asymmetric Dimethylarginine (ADMA) as Endothelial Dysfunction Marker Among Obese Men

BACKGROUND: Ghrelin has many biological activities such as regulating energy homeostasis and recent studies have shown its effects in the cardiovascular system. Ghrelin concentration decreases in obese man that indicates relatioship between ghrelin and energy homeostasis. Ghrelin also improves endot...

Full description

Bibliographic Details
Main Authors:	Lia Meliani, Mansyur Arif, Indriyanti Rafi Sukmawati
Format:	Article
Language:	English
Published:	Secretariat of The Indonesian Biomedical Journal 2012-08-01
Series:	Indonesian Biomedical Journal
Online Access:	http://inabj.org/index.php/ibj/article/view/167

Similar Items

Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis
by: Maurício Batista Paes Landim, et al.
Published: (2009-05-01)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
by: Dimitrios Tsikas, et al.
Published: (2018-01-01)

Asymmetric Dimethylarginine (ADMA) level in Serum of Preeclamptic patients
by: Faisal Gh. Al-Rubaye
Published: (2010-01-01)

Correlation between Homeostatic Model Assessment-estimated Insulin Resistance (HOMA-IR) with Asymmetric Dimethylarginine (ADMA) in Prehypertension
by: Maria Evi Novianti, et al.
Published: (2013-12-01)

P.041 ARTERIAL STIFFNESS MAY BE DETERMINED BY ASYMMETRIC DIMETHYLARGININE (ADMA)
by: S. Hickson, et al.
Published: (2007-08-01)

Study of endothelial dysfunction and asymmetric dimethylarginine levels
by: Ya. V. Sirman, et al.
Published: (2019-10-01)

Asymmetric dimethylarginine (ADMA) increases the myogenic tone of arterioles due to enhanced release of superoxide
by: Toth, J, et al.
Published: (2007)

Alterations of Asymmetric Dimethylarginine (ADMA)-Containing Protein Profiles Associated with Chronic Pancreatitis Pathogenesis
by: Tan C, et al.
Published: (2021-12-01)

Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond
by: Chien-Ning Hsu, et al.
Published: (2021-09-01)

The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
by: Emanuela Sozio, et al.
Published: (2023-06-01)

Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy.
by: Zoltan Nemeth, et al.
Published: (2015-01-01)

ELEVATED LEVELS OF ASYMMETRIC DIMETHYLARGININE (ADMA) AND SYMMETRIC DIMETHYLARGININE (SDMA) CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS
by: Landray, M, et al.
Published: (2005)

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
by: Antoniades, C, et al.
Published: (2009)

Acute effects of hyperglycaemia on asymmetric dimethylarginine (ADMA), adiponectin and inflammatory markers (IL-6, hs-CRP) in overweight and obese women with metabolic syndrome.
by: Siervo, M, et al.
Published: (2010)

Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients
by: Natasa Stanisavljevic, et al.
Published: (2022-10-01)

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice
by: Siarkos Ilias, et al.
Published: (2011-07-01)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
by: Tzong-Shyuan Lee, et al.
Published: (2021-10-01)

Author Correction: The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
by: Emanuela Sozio, et al.
Published: (2023-06-01)

Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond
by: Dimitrios Tsikas
Published: (2020-06-01)

Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis.
by: Antoniades, C, et al.
Published: (2011)

Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass
by: Johannes Jacobi, et al.
Published: (2014-03-01)

Positive correlation of airway resistance and serum asymmetric dimethylarginine (ADMA) in bronchial asthma patients lacking evidence for systemic inflammation
by: Gabor Tajti, et al.
Published: (2018-01-01)

Asymmetrical dimethylarginine as a mediator of endothelial dysfunction in acute inflammation at different disease stages
by: Demosthenous, M, et al.
Published: (2010)

P.036 ASYMMETRIC DIMETHYLARGININE AND OXIDIZED LDL – SENSITIVE BIOCHEMICAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN CHILDREN WITH FAMILIAR HYPERCHOLESTEROLEMIA☆
by: P. Jehlicka, et al.
Published: (2007-08-01)

The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine.
by: Emir Taghikhani, et al.
Published: (2019-01-01)

Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis.
by: Joshua S Davis, et al.
Published: (2011-02-01)

Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
by: Kathrin Cordts, et al.
Published: (2019-07-01)

Asymmetric dimethylarginine-induced oxidative damage leads to cerebrovascular dysfunction
by: Mushfiquddin Khan, et al.
Published: (2021-01-01)

Overexpression of alanine-glyoxylate aminotransferase 2 protects from asymmetric dimethylarginine-induced endothelial dysfunction and aortic remodeling
by: Roman N. Rodionov, et al.
Published: (2022-06-01)

Association between estimated glomerular filtration rate (eGFR) and asymmetric dimethylarginine (ADMA) concentrations among the elderly in a rural community: a cross-sectional study
by: Hye Rin Choi, et al.
Published: (2019-12-01)

Relationship between sRAGE and hsCRP as Markers of Cardiovascular Disease Risk Factors in Diabetic and Non-Diabetic Men with Central Obesity
by: Rambu Beppy Hamuaty, et al.
Published: (2017-09-01)

Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase
by: Chiao‐Po Hsu, et al.
Published: (2016-04-01)

Adiposopathy and Obesity Paradox
by: Indriyanti Rafi Sukmawati, et al.
Published: (2013-04-01)

Role of Asymmetric Dimethylarginine in Psychiatric Disorders
by: Selma Bozkurt Zincir, et al.
Published: (2014-08-01)

Renal asymmetric dimethylarginine inhibits fibrosis
by: Ming Wu, et al.
Published: (2020-10-01)

Correlation between Nitric oxide (NO) & Asymmetric dimethylargininie (ADMA) Hemoglobin
by: M Kadkhodaei Elyaderani, et al.
Published: (2010-04-01)

Early Exercise Training After Renal Transplantation and Asymmetric Dimethylarginine: The Effect of Obesity
by: Vladimír Teplan, et al.
Published: (2014-08-01)

P9.08 THE L-ARGININE/ASYMMETRIC DIMETHYLARGININE (ADMA) RATIO IS IMPROVED DURING ANTI-TUMOR NECROSIS FACTOR–α THERAPY IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES: ASSOCIATION WITH AORTIC STIFFNESS
by: K. Angel, et al.
Published: (2011-11-01)